| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/30/2008 | US7429466 Methods and arrays for detecting biological molecules |
| 09/30/2008 | US7429464 Methods for detecting bacterial pathogens |
| 09/30/2008 | US7429463 Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample |
| 09/30/2008 | US7429462 in vivo screening assay and an in vitro screening assay for rapid screening of diabetes. A method of the invention includes determining a first glucose concentration in an ocular fluid of a patient; administering orally a load of carbohydrate to the patient; determining a second glucose concentration |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429460 for treating Gaucher's disease by preventing accumulation of phosphatidylcholine (PC), wherein PC accumulation is increased due to the activation of CTP:phosphocholine cytidylyltransferase (CCT) upon glucosylceramide (GlcCer) accumulation |
| 09/30/2008 | US7429459 for identifying compounds that inhibit amyloidal-beta precursor protein processing in cells, comprising contacting a test compound with a GPCR polypeptide, or fragment thereof, and measuring a compound-GPCR property related to the production of amyloidal-beta peptide. |
| 09/30/2008 | US7429457 Id-1 and Id-2 genes and products as markers of epithelial cancer |
| 09/30/2008 | US7429456 Identification of a JAK2 mutation in Polycythemia Vera |
| 09/30/2008 | US7429455 analyzing nucleic acids. In particular, the present invention provides methods and compositions for the detection and characterization of nucleic acid sequences and sequence changes. |
| 09/30/2008 | US7429454 DNA probes useful in detecting δ-endotoxin-encoding sequences and uses thereof |
| 09/30/2008 | US7429453 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| 09/30/2008 | US7429452 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein |
| 09/30/2008 | US7429451 Nucleic acids isolated from stage 4 neuroblastoma |
| 09/30/2008 | US7429450 HIP1 cancer markers |
| 09/30/2008 | US7429449 Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels |
| 09/30/2008 | US7429448 Therapeutic use of the SMR1 protein and active derivatives thereof |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | US7429374 Determining if a batch of glatiramer acetate is acceptable for pharmaceutical use |
| 09/30/2008 | CA2627028A1 Micro-fluidic temperature driven valve |
| 09/30/2008 | CA2225390C Silicon-based sleeve devices for chemical reactions |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/25/2008 | WO2008116225A2 Surface mediated self-assembly of nanoparticles |
| 09/25/2008 | WO2008116223A1 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
| 09/25/2008 | WO2008116186A1 Systems and devices for isothermal biochemical reactions and/or analysis |
| 09/25/2008 | WO2008116161A2 Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
| 09/25/2008 | WO2008116044A1 Semiconductor quantum dots for efeicient delivery and intracellular imaging of sirna |
| 09/25/2008 | WO2008115948A2 Positive selection procedure for optically directed selection of cells |
| 09/25/2008 | WO2008115809A2 Cytokines and genes differentially affected by tnf blockers |
| 09/25/2008 | WO2008115750A2 Compositions and methods for the treatment of cancer |
| 09/25/2008 | WO2008115653A2 Smart hydrogel particles for biomarker harvesting |
| 09/25/2008 | WO2008115561A2 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents |
| 09/25/2008 | WO2008115556A2 Identification of genetic alterations that modulate drug sensitivity in cancer treatments |
| 09/25/2008 | WO2008115518A2 Biomarkers of sirtuin activity and methods of use thereof |
| 09/25/2008 | WO2008115478A2 Method of cancer detection and treatment |
| 09/25/2008 | WO2008115427A2 System and method for detection of hiv drug resistant variants |
| 09/25/2008 | WO2008115420A2 Methods for detecting molecular interactions within cells using combination of inducible promoters and biosensors |
| 09/25/2008 | WO2008115419A2 Gene expression markers for prediction of patient response to chemotherapy |
| 09/25/2008 | WO2008115387A2 Screening, diagnosing, treating and prognosis of pathophysiologic states by rna regulation |
| 09/25/2008 | WO2008115382A1 Method and apparatus for finding macromolecule crystallization conditions |
| 09/25/2008 | WO2008115054A2 A method for regulating eukaryotic gene expression at the level of chromatin |
| 09/25/2008 | WO2008115044A1 Amperometric biosensor for histamine determination |
| 09/25/2008 | WO2008115002A1 Cyclic reverse transcription method |
| 09/25/2008 | WO2008114935A1 Chip and method for determining transglutaminase activity |
| 09/25/2008 | WO2008114828A1 Cell selection method and cell selection apparatus |
| 09/25/2008 | WO2008114709A1 Biomarker specific to blood cell or specific to osteoclast differentiation |
| 09/25/2008 | WO2008114672A1 Cancer-specific biomarker |
| 09/25/2008 | WO2008114622A1 Oxidative color-developing compounds, salts thereof, process for production of the same, reagent compositions and test tools made by using the same |
| 09/25/2008 | WO2008114544A1 Probe for visualizing cell cycle |
| 09/25/2008 | WO2008114282A2 Transgenic rice (oryza sativa) comprising pe-7 event and method of detection thereof |
| 09/25/2008 | WO2008114237A2 Marker sequences for labour |
| 09/25/2008 | WO2008114077A1 Constitutively active mutants of the prolactin receptor |
| 09/25/2008 | WO2008114001A1 Esbl detection kit and method |
| 09/25/2008 | WO2008114000A1 Methods of producing haploid and doubled haploid oil palms |
| 09/25/2008 | WO2008113870A1 Method for the diagnosis and/or prognosis of cancer of the bladder |
| 09/25/2008 | WO2008113773A2 Gene expression regulation technology and noncoding rnas for diagnosis and therapy |
| 09/25/2008 | WO2008113174A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | WO2008113119A1 A cell-mediated immune response assay and kits therefor |
| 09/25/2008 | WO2008113111A1 Assay for gene expression |
| 09/25/2008 | WO2008093083A3 Prognostic markers for hpv-related cancer |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008081435A3 Methods and kits for predicting prognosis of multiple sclerosis |
| 09/25/2008 | WO2008081066A8 Method for detecting and identifying peronospora arborescens |
| 09/25/2008 | WO2008079243A3 Integrated screening assays and methods of use |
| 09/25/2008 | WO2008073629A9 Bifunctional predictors of cancer treatment sensitivity and resistance |
| 09/25/2008 | WO2008060368A3 Transglutaminase-binding peptides and methods of use |
| 09/25/2008 | WO2008049930A3 A method for profiling kinase inhibitors |
| 09/25/2008 | WO2008048639A9 Genetic prediction of schizophrenia susceptibility |
| 09/25/2008 | WO2008043987A3 Methods for amplifying and detecting nucleic acid sequences |
| 09/25/2008 | WO2008030616A3 Monitoring cancer stem cells |
| 09/25/2008 | WO2008027428A3 Gene expression profiling for identification, monitoring and treatment of transplant rejection |
| 09/25/2008 | WO2007149065A3 Methods and apparatuses for detecting chemical or biological agents |
| 09/25/2008 | WO2007146336A3 Molecular determinants associated with enhanced ability to enter cells expressing cxcr4 |
| 09/25/2008 | WO2007143752A3 Targets in breast cancer for prognosis or therapy |
| 09/25/2008 | WO2007143548A3 Myxoma virus mutants for cancer treatment |
| 09/25/2008 | WO2007128984A3 Breast cancer makers |
| 09/25/2008 | WO2007095185A3 Variants in complement regulatory genes predict age-related macular degeneration |
| 09/25/2008 | WO2007090401A8 Calving characteristics |
| 09/25/2008 | WO2005113795A3 Hematology reference control containing an immature granulocyte component |
| 09/25/2008 | US20080235826 useful in the production of dwarf plants; type 5 serine/threonine protein phosphatase activity; production of plants sensitive to light signal transduction |
| 09/25/2008 | US20080235825 Methods and means for modulating cellulose biosynthesis in fiber producing |
| 09/25/2008 | US20080234473 Oligonucleotide probe for use as diagnostic indicator in dection of urogenital infections |
| 09/25/2008 | US20080234471 Dna sequence; open-reading frame; genetic engineering |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234468 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders |
| 09/25/2008 | US20080234393 Compounds and methods for detection of carcinomas and their precursor lesions |
| 09/25/2008 | US20080234379 Therapeutic methods employing nitric oxide precursors |
| 09/25/2008 | US20080234265 combination of at least one selective histone deacetylase inhibitor (suberoylanilidine hydroxamic acid, valproic acid) and kinase inhibitor with anti-EGFR activity (gefitinib, erlotinib); anticarcinogenic agent; non-small cell lung, breast, bladder, colon, prostate, uterine, cervical, ovarian cancer |
| 09/25/2008 | US20080234264 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 09/25/2008 | US20080234223 5-azacytidine pyrimidine analog is epigenetic agent histone deacetylase inhibitor; inhibits nucleic acid methylation through an N4 carboxylester or ester bond; acetylcholine cell-targeting agent; cell expresses acetylcholinesterase; central nervous system; liver cancer |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234217 Double stranded nucleotide sequences for use as tools in tissue targeted gene expression inhibition and treatment of cancer, vascular, neuronal and endocrine diseases |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234213 Oncogenic regulatory RNAs for diagnostics and therapeutics |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234191 Depleting complement; treatment of diseases such as reperfusion injury, autoimmune diseases, and other diseases of increased complement activation; increasing the efficiency and/or effectiveness of gene therapy; may be chemically linked to an antibody with an affinity for a specific tissue |
| 09/25/2008 | US20080234187 In particular amidated, acetylated, phosphorylated and/or glycosylated derivatives; diagnostic agents including a nucleic acid or messenger RNA coding for the cytokine; isolated from human hemofiltrate |